Vimarsana
Biggest News Aggregation in the World

Page 29 - Entrypoint Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Entrypoint Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Entrypoint Capital Today - Breaking & Trending Today

American Woodmark (NASDAQ:AMWD) Shares Gap Down After Earnings Miss - Vimarsana News

American Woodmark (NASDAQ:AMWD) Shares Gap Down After Earnings Miss

American Woodmark Co. (NASDAQ:AMWD – Get Free Report) shares gapped down prior to trading on Friday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $92.66, but opened at $85.34. American Woodmark shares last traded at $85.84, with a volume of 45,744 shares changing hands. The company reported $1.70 […]

Lindsay Co. (NYSE:LNN) Receives $138.33 Consensus Target Price from Analysts - Vimarsana News

Lindsay Co. (NYSE:LNN) Receives $138.33 Consensus Target Price from Analysts

Lindsay Co. (NYSE:LNN – Get Free Report) has earned an average rating of “Moderate Buy” from the four research firms that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 month target price among […]

KKR Real Estate Finance Trust Inc. (NYSE:KREF) Receives Consensus Rating of "Moderate Buy" from Analysts - Vimarsana News

KKR Real Estate Finance Trust Inc. (NYSE:KREF) Receives Consensus Rating of "Moderate Buy" from Analysts

KKR Real Estate Finance Trust Inc. (NYSE:KREF – Get Free Report) has received an average rating of “Moderate Buy” from the six analysts that are covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average […]

Source: wkrb13.com
HC Wainwright Lowers Cytokinetics (NASDAQ:CYTK) Price Target to $90.00 - Vimarsana News

HC Wainwright Lowers Cytokinetics (NASDAQ:CYTK) Price Target to $90.00

Cytokinetics (NASDAQ:CYTK – Get Free Report) had its target price dropped by equities researchers at HC Wainwright from $94.00 to $90.00 in a research report issued on Thursday, Benzinga reports. The firm presently has a “buy” rating on the biopharmaceutical company’s stock. HC Wainwright’s target price suggests a potential upside of 86.34% from the company’s […]

Royal Bank of Canada Cuts Chemed (NYSE:CHE) Price Target to $697.00 - Vimarsana News

Royal Bank of Canada Cuts Chemed (NYSE:CHE) Price Target to $697.00

Chemed (NYSE:CHE – Free Report) had its price target cut by Royal Bank of Canada from $712.00 to $697.00 in a research report released on Tuesday morning, Benzinga reports. They currently have an outperform rating on the stock. Several other brokerages have also recently issued reports on CHE. Oppenheimer boosted their price target on Chemed […]

Source: wkrb13.com